Clinical Trial Update: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ticagrelor plus aspirin dual antiplatelet therapy with intravenous thrombolysis for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Aspirin (Aspirin)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, Acute | Phase 3 | Status: COMPLETED